|
1
|
Byun BH, Jeong UG, Hong SP, Min JJ, Chong
A, Song HC and Bom HS: Prediction of central lymph node metastasis
from papillary thyroid microcaprcinoma by
18F-fluorodeoxyglucose PET/CT and ultrasonography. Ann
Nucl Med. 26:471–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeh MW, Bauer AJ, Bernet VA, Ferris RL,
Loevner LA, Mandel SJ, Orloff LA, Randolph GW and Steward DL:
American Thyroid Association Surgical Affairs Committee Writing
Task Force: American Thyroid Association statement on preoperative
imaging for thyroid cancer surgery. Thyroid. 25:3–14. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pak K, Kim SJ, Kim IJ, Kim BH, Kim SS and
Jeon YK: The role of 18F-fluorodeoxyglucose positron emission
tomography in differentiated thyroid cancer before surgery. Endocr
Relat Cancer. 20:R203–R213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kresnik E, Gallowitsch HJ, Mikosch P,
Stettner H, Igerc I, Gomez I, Kumnig G and Lind P:
Fluorine-18-fluorodeoxyglucose positron emission tomography in the
preoperative assessment of thyroid nodules in an endemic goiter
area. Surgery. 133:294–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fujii T, Yajima R, Yamaguchi S, Tsutsumi
S, Asao T and Kuwano H: Is it possible to predict malignancy in
cases with focal thyroid incidentaloma identified by
18F-fluorodeoxyglucose positron emission tomography? Am
Surg. 78:141–143. 2012.PubMed/NCBI
|
|
6
|
Wu YJ, Wu HS, Yen RF, Shen YY and Kao CH:
Detecting metastatic neck lymph nodes in papillary thyroid
carcinoma by 18F-2-deoxyglucose positron emission
tomography and Tc-99m tetrofosmin single photon emission computed
tomography. Anticancer Res. 23:2973–2976. 2003.PubMed/NCBI
|
|
7
|
Marcus C, Whitworth PW, Surasi DS, Pai SI
and Subramaniam RM: PET/CT in the management of thyroid cancers.
AJR Am J Roentgenol. 202:1316–1329. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y: Clinical significance of thyroid
uptake on F18-fluorodeoxyglucose positron emission tomography. Ann
Nucl Med. 23:17–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fletcher JW, Djulbegovic B, Soares H,
Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC,
Avril N, et al: Recommendations on the use of 18F-FDG
PET in oncology. J Nucl Med. 49:480–508. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Urhan M, Velioglu M, Rosenbaum J, Basu S
and Alavi A: Imaging for the diagnosis of thyroid cancer. Expert
Opin Med diagn. 3:237–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi JW, Yoon YH, Yoon YH, Kim SM and Koo
BS: Characteristics of primary papillary thyroid carcinoma with
false-negative findings on initial 18F-FDG PET/CT. Ann
Surg Oncol. 18:1306–1311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeong HS, Baek CH, Son YI, Choi JY, Kim
HJ, Ko YH, Chung JH and Baek HJ: 18F-FDG PET/CT for the
initial evaluation of cervical node level of patients with
papillary thyroid carcinoma: comparison with ultrasound and
contrast-enhanced CT. Clin Endocrinol (Oxf). 65:402–407. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morita S, Mizoguchi K, Suzuki M and Iizuka
K: The accuracy of [18 F]-fluoro-2-deoxy
D-glucose-positron emission tomography/computed tomography,
ultrasonography, and enhanced computed tomography alone in the
preoperative diagnosis of cervical lymph node metastasis in
patients with papillary thyroid carcinoma. World J Surg.
34:2564–2569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohba K, Nishizawa S, Matsushita A,
Inubushi M, Nagayama K, Iwaki H, Matsunaga H, Suzuki S, Sasaki S,
Oki Y, et al: High incidence of thyroid cancer in focal thyroid
incidentaloma detected by 18F-fluorodeoxyglucose
[corrected] positron emission tomography in relatively young
healthy subjects: Results of 3-year follow-up. Endocr J.
57:395–401. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bae JS, Chae BJ, Park WC, Kim JS, Kim SH,
Jung SS and Song BJ: Incidental tyroid lesions detected by
FDG-PET/CT: Prevalence and risk of thyroid cancer. World J Surg
Oncol. 7:632009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ,
Park K, Baek CH, Chung JH, Lee KH and Kim BT: Focal thyroid lesions
incidentally identified by integrated 18F-FDG PET/CT:
Clinical significance and improved characterization. J Nucl Med.
47:609–615. 2006.PubMed/NCBI
|
|
17
|
Matsuzu K, Segade F, Matsuzu U, Carter A,
Bowden DW and Perrier ND: Differential expression of glucose
transporters in normal and pathologic thyroid tissue. Thyroid.
14:806–812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoffman EJ, Huang SC and Phelps ME:
Quantitation in positron emission computed tomography: 1. Effect of
object size. J Comput Assist Tomogr. 3:299–308. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deichen JT, Schmidt C, Prante O, Maschauer
S, Papadopoulos T and Kuwert T: Influence of TSH on uptake of
[18F]fluorodeoxyglucose in human thyroid cells in vitro.
Eur J Nucl Med Mol Imaging. 31:507–512. 2004. View Article : Google Scholar : PubMed/NCBI
|
